TL;DR
- •Entrepreneurs have higher rates of depression, anxiety, and ADHD-spectrum patterns than the general population — research from UCSF, Berkeley, and Stanford consistently finds 30-50% prevalence of clinically meaningful mental-health symptoms in founder samples.
- •The founder profile (high openness, intensity, comfort with risk) overlaps with traits that also predispose to depression and anxiety — and the stressors of running a business amplify both.
- •Telehealth ketamine therapy fits the entrepreneur schedule — no clinic visits, completely flexible timing, total privacy from investors, employees, and co-founders.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses insurance entirely, which matters when investors review founder backgrounds or when buyers conduct due diligence.
- •For treatment-resistant cases where SSRIs and therapy alone haven't produced enough response, ketamine's rapid mechanism can produce noticeable change within days — useful when an entrepreneur can't take 6-12 weeks of titration time off.
- •Most founder-patients say what mattered most was: complete privacy; ability to schedule around investor meetings and product launches; same physician every visit; no insurance record visible to anyone.
The stressors specific to your work
- •Personal financial risk concentrated in the business — failure costs are existential
- •Decision fatigue at a volume and consequence level most jobs never reach
- •Loneliness — co-founders aren't therapists, and team members can't hold founder anxieties
- •Identity fusion with the company — wins and losses feel personal
- •Sleep disruption from investor calls across time zones, customer crises, and product issues
- •Performance pressure — investors, employees, and customers all depending on the founder's capacity
Why telehealth works for entrepreneurs
- •No commute — fits between investor pitches, customer calls, and team standups
- •Sessions evenings or weekends, no need to explain time away from the company
- •Treatment in your own home or office — completely private
- •Same physician every visit — continuity matters when bandwidth is scarce
- •Compatible with high-travel founder schedules within FL/NJ residency
Privacy considerations
- •Tovani is direct-pay — no insurance claim tied to any health plan
- •Founder mental-health treatment is private and not visible to investors, board members, co-founders, or employees without your explicit written authorization
- •M&A due diligence typically focuses on company financials and operations — personal medical records are not standard discovery items
- •For founders considering D&O insurance or key-person life insurance, the underwriting questions vary; consult an insurance broker for specifics
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my investors or board find out?
No. Tovani is a private medical practice with HIPAA protections — your mental health treatment is not visible to investors, board members, employees, or any business stakeholders. There's no insurance claim, no third-party billing record, and no employer EAP involvement.
I can't take 6 weeks off to wait for SSRIs to work. What about ketamine?
Ketamine's rapid-action mechanism (often within hours or days) is exactly the case where it provides clinical value beyond SSRIs. For treatment-resistant cases where you've already tried SSRIs without enough response, or where you need faster intervention for an acute period, ketamine is often the right next step.
How does this affect M&A due diligence or selling my company?
Personal medical records are not standard items in M&A due diligence — buyers focus on company financials, operations, contracts, and IP. Your private mental-health treatment doesn't appear in any business records visible to acquirers. If you're selling, the cleaner the better — direct-pay private practice keeps your health record entirely separate from your business records.
I'm worried I'll become "less driven" if I treat my depression / anxiety. Will I?
This is the most common founder concern and the research consensus is clear: treating clinical depression or anxiety does NOT reduce drive or ambition — it removes the suffering that was making the drive feel destructive. Most founder-patients report MORE sustainable productivity post-treatment, not less. The "my mental-health issues fuel my success" framing usually doesn't survive contact with effective treatment.
Can I do this while running my company?
Yes. Telehealth ketamine therapy is designed for working patients. Sessions are 1-2 hours including recovery; by the next morning you're fully back to baseline. Many founder-patients schedule sessions Friday evenings or weekend mornings to minimize disruption. The maintenance phase (monthly sessions after the initial 4-6 week phase) integrates easily into ongoing work.
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — relevant for high-functioning patients (entrepreneurs frequently fit this profile) who maintain external function while internal symptoms persist. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid-action mechanism — useful when timeline-pressured patients need faster response than the typical 6-12 week SSRI titration allows. PMID 28249076